84 related articles for article (PubMed ID: 6604142)
1. C-11 dimethyloxazolidinedione (DMO): biodistribution, radiation absorbed dose, and potential for PET measurement of regional brain pH: concise communication.
Kearfott KJ; Junck L; Rottenberg DA
J Nucl Med; 1983 Sep; 24(9):805-11. PubMed ID: 6604142
[TBL] [Abstract][Full Text] [Related]
2. In vivo measurement of regional brain and tumor pH using [14C]dimethyloxazolidinedione and quantitative autoradiography.
Arnold JB; Junck L; Rottenberg DA
J Cereb Blood Flow Metab; 1985 Sep; 5(3):369-75. PubMed ID: 4030915
[TBL] [Abstract][Full Text] [Related]
3. In vivo measurement of brain tumor pH using [11C]DMO and positron emission tomography.
Rottenberg DA; Ginos JZ; Kearfott KJ; Junck L; Dhawan V; Jarden JO
Ann Neurol; 1985 Jan; 17(1):70-9. PubMed ID: 3872621
[TBL] [Abstract][Full Text] [Related]
4. Radiation absorbed dose estimates for positron emission tomography (PET): K-38, Rb-81, Rb-82, and Cs-130.
Kearfott KJ
J Nucl Med; 1982 Dec; 23(12):1128-32. PubMed ID: 6982966
[TBL] [Abstract][Full Text] [Related]
5. In vivo measurement of regional brain tissue pH using positron emission tomography.
Rottenberg DA; Ginos JZ; Kearfott KJ; Junck L; Bigner DD
Ann Neurol; 1984; 15 Suppl():S98-102. PubMed ID: 6611132
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vivo characteristics of [2-11 C]5,5-dimethyloxazolidine-2,4-dione (DMO).
Berridge M; Comar D; Roeda D; Syrota A
Int J Appl Radiat Isot; 1982 Aug; 33(8):647-51. PubMed ID: 6981609
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of [2-11C]5,5-dimethyl-2,4-oxazolidinedione for studies with positron tomography.
Ginos JZ; Tilbury RS; Haber MT; Rottenberg DA
J Nucl Med; 1982 Mar; 23(3):255-8. PubMed ID: 6977626
[TBL] [Abstract][Full Text] [Related]
8. Human biodistribution and dosimetry of the PET perfusion agent copper-62-PTSM.
Wallhaus TR; Lacy J; Whang J; Green MA; Nickles RJ; Stone CK
J Nucl Med; 1998 Nov; 39(11):1958-64. PubMed ID: 9829589
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of [11C]hemicholinium-15 and [18F]hemicholinium-15 as new potential PET tracers for the high-affinity choline uptake system in the heart.
Gao M; Miller MA; DeGrado TR; Mock BH; Lopshire JC; Rosenberger JG; Dusa C; Das MK; Groh WJ; Zipes DP; Hutchins GD; Zheng QH
Bioorg Med Chem; 2007 Feb; 15(3):1289-97. PubMed ID: 17116396
[TBL] [Abstract][Full Text] [Related]
10. Absorbed dose estimates for positron emission tomography (PET): C15O, 11CO, and CO15O.
Kearfott KJ
J Nucl Med; 1982 Nov; 23(11):1031-7. PubMed ID: 6813432
[No Abstract] [Full Text] [Related]
11. Comparison of DMO and flow cytometric methods for measuring intracellular pH and the effect of hyperthermia on the transmembrane pH gradient.
Wang ZH; Chu GL; Hyun WC; Pershadsingh HA; Fulwyler MJ; Dewey WC
Cytometry; 1990; 11(5):617-23. PubMed ID: 2379453
[TBL] [Abstract][Full Text] [Related]
12. A new, simple, high-yield synthesis of "no-carrier-added" 11C-labelled DMO.
Diksic M
Int J Appl Radiat Isot; 1984 Nov; 35(11):1035-7. PubMed ID: 6335491
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of [(11)C]rofecoxib as PET tracer for cyclooxygenase 2 overexpression in rat models of inflammation.
de Vries EF; Doorduin J; Dierckx RA; van Waarde A
Nucl Med Biol; 2008 Jan; 35(1):35-42. PubMed ID: 18158941
[TBL] [Abstract][Full Text] [Related]
14. Labeled choline and phosphorylcholine: body distribution and brain autoradiography: concise communication.
Friedland RP; Mathis CA; Budinger TF; Moyer BR; Rosen M
J Nucl Med; 1983 Sep; 24(9):812-5. PubMed ID: 6604143
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
16. Intracellular pH transients in rainbow trout tissues measured by dimethadione distribution.
Milligan CL; Wood CM
Am J Physiol; 1985 Jun; 248(6 Pt 2):R668-73. PubMed ID: 4003577
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and initial PET imaging of new potential NK1 receptor radioligands 1-[2-(3,5-bis-trifluoromethyl-benzyloxy)-1-phenyl-ethyl]-4-[11C]methyl-piperazine and {4-[2-(3,5-bis-trifluoromethyl-benzyloxy)-1-phenyl-ethyl]-piperazine-1-yl}-acetic acid [11C]methyl ester.
Gao M; Mock BH; Hutchins GD; Zheng QH
Nucl Med Biol; 2005 Jul; 32(5):543-52. PubMed ID: 15982585
[TBL] [Abstract][Full Text] [Related]
18. Radiation dose estimates in humans for (11)C-acetate whole-body PET.
Seltzer MA; Jahan SA; Sparks R; Stout DB; Satyamurthy N; Dahlbom M; Phelps ME; Barrio JR
J Nucl Med; 2004 Jul; 45(7):1233-6. PubMed ID: 15235071
[TBL] [Abstract][Full Text] [Related]
19. Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography.
Wilson AA; McCormick P; Kapur S; Willeit M; Garcia A; Hussey D; Houle S; Seeman P; Ginovart N
J Med Chem; 2005 Jun; 48(12):4153-60. PubMed ID: 15943487
[TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of ethyl [(18)F]fluoroacetate as a proradiotracer of [(18)F]fluoroacetate for the measurement of glial metabolism by PET.
Mori T; Sun LQ; Kobayashi M; Kiyono Y; Okazawa H; Furukawa T; Kawashima H; Welch MJ; Fujibayashi Y
Nucl Med Biol; 2009 Feb; 36(2):155-62. PubMed ID: 19217527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
